Inhibrx Biosciences, Inc. INBX Interest Expense
Interest Expense at other companies
Other financials
Where this comes from
Reported directly by Inhibrx Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Inhibrx Biosciences, Inc.'s interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Inhibrx Biosciences, Inc.'s interest expense?
- Inhibrx Biosciences, Inc. (INBX) reported interest expense of $3.51M in Q1 2026.
- How has Inhibrx Biosciences, Inc.'s interest expense changed year-over-year?
- Inhibrx Biosciences, Inc.'s interest expense increased by 30.5% year-over-year, from $2.69M to $3.51M.
- What is the long-term trend for Inhibrx Biosciences, Inc.'s interest expense?
- Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s interest expense has grown at a -38.1% compound annual growth rate (CAGR), from $31.84M to $12.2M.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.